Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 7

1.

A comparative clinical trial of adriamycin and 5-fluorouracil in advanced prostatic cancer: prognostic factors and response.

DeWys WD, Begg CB, Brodovsky H, Creech R, Khandekar J.

Prostate. 1983;4(1):1-11.

PMID:
6340081
2.

Racial disparity in clinical course and outcome of metastatic androgen-independent prostate cancer.

Thatai LC, Banerjee M, Lai Z, Vaishampayan U.

Urology. 2004 Oct;64(4):738-43. Review.

PMID:
15491712
3.

A systematic overview of chemotherapy effects in colorectal cancer.

Ragnhammar P, Hafström L, Nygren P, Glimelius B; SBU-group. Swedish Council of Technology Assessment in Health Care.

Acta Oncol. 2001;40(2-3):282-308. Review.

PMID:
11441937
4.

The chemotherapy of prostatic adenocarcinoma.

Torti FM, Carter SK.

Ann Intern Med. 1980 May;92(5):681-9. Review.

PMID:
6992675
5.

Prognostic factors in metastatic prostate cancer.

Matzkin H, Perito PE, Soloway MS.

Cancer. 1993 Dec 15;72(12 Suppl):3788-92. Review.

6.

Proceedings: Non-hormonal cytotoxic agents in the treatment of prostatic adenocarcinoma.

Yagoda A.

Cancer. 1973 Nov;32(5):1131-40. Review. No abstract available.

7.

Time-dependent prognostic factors in advanced prostatic cancer.

Suciu S, Sylvester RJ, Yamanaka H.

Prog Clin Biol Res. 1990;357:203-15. Review. No abstract available.

PMID:
2217465

Supplemental Content

Support Center